Sort   by:  
 Page size 
UnknownDevelopment of the SaFETy Score: A Clinical Screening Tool for Predicting Future Firearm Violence Risk.
Not available
S-EPMC5697901 | biostudies-literature
UnknownComparative effectiveness of metronidazole and vancomycin for treatment of <i>Clostridioides difficile</i> infection in hospitalized children.
Not available
S-EPMC11920915 | biostudies-literature
UnknownPemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer: ECOG-ACRIN 5508.
Not available
S-EPMC7001786 | biostudies-literature
UnknownErlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial.
Not available
S-EPMC5154681 | biostudies-literature
UnknownAntiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment.
Not available
S-EPMC11026387 | biostudies-literature
UnknownTelomere length is not a main factor for the development of islet autoimmunity and type 1 diabetes in the TEDDY study.
Not available
S-EPMC8927592 | biostudies-literature
Unknown20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
Not available
S-EPMC5734609 | biostudies-literature
Sort   by:  
 Page size